Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion type Assertion NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_head.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion description "[Resistance to anti?human epidermal growth factor receptor, hormonal or anti-PI3K therapies have been described in breast carcinomas bearing activation of the PI3K signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_provenance.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion evidence source_evidence_literature NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_provenance.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion SIO_000772 23314198 NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_provenance.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion wasDerivedFrom befree-2016 NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_provenance.
- NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_assertion wasGeneratedBy ECO_0000203 NP1043184.RA-6GJRkCc4z0cTownijcepKsO9P0jHZkQ5A0THx5oMUY130_provenance.